Allochronic overlapping malignancies after renal transplantation in a patient with p53 gene mutation: report of a case

Surg Today. 2004;34(5):473-6. doi: 10.1007/s00595-003-2713-1.

Abstract

We report a rare case of the development of various tumors over a 16-year period after renal transplantation. A 56-year-old woman underwent renal transplantation using a US kidney. Immunosuppressive treatment consisted of a triple regimen of methylprednisolone, azathioprine, and mizoribine. Left breast cancer was diagnosed 9 years after the renal transplantation, then colon cancers and meningeal epidermal meningioma were diagnosed, 10 years and 12 years post-transplant, respectively. During the investigations for the breast and colon cancers, a p53 gene mutation was detected. A deterioration of renal function was found 16 years after the transplant and graft biopsy confirmed chronic rejection. We suggest that the effects of the immunosuppressive drugs combined with the p53 gene abnormality accelerated tumor development in this patient.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Azathioprine / administration & dosage
  • Breast Neoplasms / etiology*
  • Breast Neoplasms / genetics
  • Breast Neoplasms / surgery
  • Carcinoma, Ductal, Breast / etiology
  • Carcinoma, Ductal, Breast / genetics
  • Colonic Neoplasms / etiology*
  • Colonic Neoplasms / genetics
  • Colonic Neoplasms / surgery
  • Colonic Polyps / etiology
  • Colonic Polyps / surgery
  • Drug Therapy, Combination
  • Female
  • Genes, p53*
  • Graft Rejection
  • Hemangioma / pathology
  • Humans
  • Immunosuppressive Agents / administration & dosage*
  • Kidney Transplantation / adverse effects*
  • Liver Neoplasms / secondary
  • Methylprednisolone / administration & dosage
  • Middle Aged
  • Mutation*
  • Neoplasms, Multiple Primary*
  • Postoperative Complications
  • Ribonucleosides / administration & dosage

Substances

  • Immunosuppressive Agents
  • Ribonucleosides
  • mizoribine
  • Azathioprine
  • Methylprednisolone